Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2322
mi
from 91732
Miami, FL
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Allied Biomedical Research Institute
2322
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2315
mi
from 91732
Miami, FL
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Miami Dade Medical Research Institute
2315
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2123
mi
from 91732
Pinellas Park, FL
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
PharmaSeek LLC (DMI Research)
2123
mi
from 91732
Pinellas Park, FL
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
1924
mi
from 91732
Decatur, GA
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
iResearch Atlanta LLC
1924
mi
from 91732
Decatur, GA
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2129
mi
from 91732
Savannah, GA
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
RTR Medical Group
2129
mi
from 91732
Savannah, GA
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2418
mi
from 91732
Manchester Township, NJ
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Mid-Atlantic Geriatric/ARC
2418
mi
from 91732
Manchester Township, NJ
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2033
mi
from 91732
Cleveland, OH
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Cleveland Clinic Foundation
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2121
mi
from 91732
Pittsburgh, PA
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2185
mi
from 91732
Charleston, SC
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Roper St. Francis Healthcare
2185
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
1602
mi
from 91732
Cordova, TN
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Wesley Neurology Clinic
1602
mi
from 91732
Cordova, TN
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2281
mi
from 91732
Washington, D.C.,
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Howard University
2281
mi
from 91732
Washington, D.C.,
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
2399
mi
from 91732
Mount Arlington, NJ
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
The Neurocognitive Institute, LLC
2399
mi
from 91732
Mount Arlington, NJ
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
6026
mi
from 91732
Elche,
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Hospital General de Elche
6026
mi
from 91732
Elche,
Click here to add this to my saved trials
CPC-201 Alzheimer's Disease Type Dementia: PET Study
Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study
Status: Enrolling
Updated:  8/8/2017
1949
mi
from 91732
West Bloomfield Township, MI
CPC-201 Alzheimer's Disease Type Dementia: PET Study
Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study
Status: Enrolling
Updated: 8/8/2017
Henry Ford Health System--West Bloomfield Hospital
1949
mi
from 91732
West Bloomfield Township, MI
Click here to add this to my saved trials
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated:  9/14/2017
961
mi
from 91732
Seattle, WA
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated: 9/14/2017
Univ of Washington
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Preliminary Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  10/3/2017
14
mi
from 91732
Glendale, CA
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Preliminary Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 10/3/2017
California Clinical Trials Medical Center
14
mi
from 91732
Glendale, CA
Click here to add this to my saved trials
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Status: Enrolling
Updated:  10/5/2017
2277
mi
from 91732
Bethesda, MD
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers
Status: Enrolling
Updated:  10/5/2017
2486
mi
from 91732
New Haven, CT
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers
Status: Enrolling
Updated: 10/5/2017
Molecular Neuroimaging, LLC
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Status: Enrolling
Updated:  10/9/2017
328
mi
from 91732
Stanford, CA
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Status: Enrolling
Updated: 10/9/2017
Stanford University
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
326
mi
from 91732
Palo Alto, CA
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
326
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
2313
mi
from 91732
Deerfield Beach, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2313
mi
from 91732
Deerfield Beach, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
2315
mi
from 91732
Hialeah, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2315
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
2235
mi
from 91732
Melbourne, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2235
mi
from 91732
Melbourne, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
2308
mi
from 91732
Plantation, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2308
mi
from 91732
Plantation, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
2134
mi
from 91732
Tampa, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
2134
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
1898
mi
from 91732
Centerville, OH
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1898
mi
from 91732
Centerville, OH
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
1251
mi
from 91732
Tulsa, OK
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1251
mi
from 91732
Tulsa, OK
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
1762
mi
from 91732
Nashville, TN
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
mi
from 91732
Graz-Eggenberg,
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from 91732
Graz-Eggenberg,
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
21
mi
from 91732
Orange, CA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
355
mi
from 91732
San Francisco, CA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
355
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2312
mi
from 91732
Boca Raton, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2312
mi
from 91732
Boca Raton, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2315
mi
from 91732
Fort Lauderdale, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2315
mi
from 91732
Fort Lauderdale, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2324
mi
from 91732
Miami Beach, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2324
mi
from 91732
Miami Beach, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2321
mi
from 91732
Miami, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2180
mi
from 91732
Port Charlotte, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2180
mi
from 91732
Port Charlotte, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2304
mi
from 91732
West Palm Beach, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2304
mi
from 91732
West Palm Beach, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1939
mi
from 91732
Snellville, GA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1939
mi
from 91732
Snellville, GA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1573
mi
from 91732
Saint Louis, MO
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1300
mi
from 91732
Omaha, NE
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
mi
from 91732
Long Branch, NJ
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from 91732
Long Branch, NJ
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2416
mi
from 91732
Manchester Township, NJ
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
2416
mi
from 91732
Manchester Township, NJ
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2426
mi
from 91732
Toms River, NJ
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2426
mi
from 91732
Toms River, NJ
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1959
mi
from 91732
Columbus, OH
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1897
mi
from 91732
Dayton, OH
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1164
mi
from 91732
Oklahoma City, OK
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
2143
mi
from 91732
Greensburg, PA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2143
mi
from 91732
Greensburg, PA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1763
mi
from 91732
Nashville, TN
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1213
mi
from 91732
Austin, TX
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1213
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
1357
mi
from 91732
Houston, TX
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials